Phaeochromocytoma

Cards (20)

  • A phaeochromocytoma is a tumour of the adrenal glands that secretes unregulated and excessive amounts of catecholamines:
    • Adrenaline
    • Noradrenaline
    • Dopamine
  • Chromaffin cells are predominantly found in the adrenal medulla, but also in the sympathetic paravertebral ganglia of the thorax, abdomen, and pelvis.
  • Up to 40% of phaeochromocytomas may have a hereditary component. Three familial syndromes are strongly associated with these catecholamine-secreting tumours:
    • MEN2
    • Von Hippel-Lindau (VHL) syndrome
    • NF type 1
  • Phaeochromocytomas are neuroendocrine tumours arising from chromaffin cells.
  • Catecholamines have wide-ranging effects as part of the normal sympathetic nervous system through activation of alpha and beta-adrenergic receptors. These effects include:
    • Alpha-adrenergic: elevated bloods pressure, increased cardiac contractility, increased glucose utilisation (glycogenolysis/gluconeogenesis).
    • Beta-adrenergic: increased heart rate, increased cardiac contractility.
  • The major concern is a sudden dramatic release in catecholamines leading to a 'hypertensive' or 'phaeochromocytoma' crisis.
    • Drugs - opiates, beta blockers, cocaine
    • Physical - direct pressure or handling during surgery
    • Anaesthesia - intubation
  • Phaeochromocytomas are characterised by a triad of episodic headache, sweating and tachycardia.
  • Classically, clinical features of phaeochromocytoma are paroxysmal. However, some patients may have more persistent symptoms, while others are asymptomatic.
  • Symptoms:
    • Headache
    • Sweating
    • Tachycardia
    • Palpitations
    • Dyspnoea
    • Weakness
    • Tremor
    • Nausea
  • Signs:
    • Hypertension
    • Postural hypotension
    • Weight loss
    • Pallor
    • Arrhythmias
    • Pulmonary oedema
    • Fever
    • Tremor
  • Patients may develop severe symptoms relating to a hypertensive crisis, also known as a phaeochromocytoma crisis. If severe, it may lead to circulatory collapse.
    • Hypertension
    • Hyperthermia
    • Confusion
    • End-organ dysfunction (e.g. cardiomyopathy, pulmonary oedema)
    • Hypertension
  • Who to test:
    • Classic triad
    • Hyperadrenergic spells  (paroxysmal palpitations, sweating, headache, tremor, pallor)
    • Atypical hypertension (early onset, resistant to treatment)
    • Associated familial syndrome
    • Family history
    • Typical adrenal adenoma on imagine
  • Initial tests include:
    • Plasma free metanephrines
    • 24-hour urine catecholamines
  • Measuring the serum catecholamine or adrenaline level is unreliable as the levels fluctuate and have a very short half-life of only a minute or so. Metanephrines (a breakdown product of adrenaline) have a longer half-life with more stable levels.
  • CT or MRI can be used to look for the tumour.
  • The definitive management of a phaeochromocytoma is surgical resection following medical optimisation.
  • The most effective method to control blood pressure is combined alpha and beta-adrenergic blockade. Beta-blockers should never be used as single therapy as it can precipitate hypertensive crisis
  • Patients are encouraged to have a high sodium diet due to the volume loss with excessive catecholamines and increased risk of orthostatic hypotension with alpha-blockers.
  • Complications:
    • Cardiac: cardiomyopathy, cardiac arrhythmias, hypertension
    • Metabolic: Type 2 diabetes mellitus
    • Neurological: stroke, seizure, cerebral haemorrhage (usually from hypertensive crisis)
    • Post-surgical: recurrent disease, adrenal insufficiency (if bilateral resection)
  • The alpha-blocker typically used is phenoxybenzamine